Hillsdale Investment Management Inc. - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 231 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
Hillsdale Investment Management Inc. ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$4,598,184
-20.4%
226,400
+0.4%
0.39%
-25.5%
Q3 2022$5,779,000
-2.4%
225,400
-9.5%
0.52%
+10.1%
Q2 2022$5,922,000
+6.2%
249,000
+0.6%
0.47%
+31.7%
Q1 2022$5,576,000
+72.8%
247,600
+33.5%
0.36%
+13.9%
Q3 2020$3,226,000
+3.4%
185,4000.0%0.32%
+11.3%
Q2 2020$3,119,000
+136.1%
185,400
+130.9%
0.28%
+54.3%
Q1 2018$1,321,000
-19.0%
80,300
-11.1%
0.18%
-30.0%
Q4 2017$1,631,000
-6.4%
90,3000.0%0.26%
-10.5%
Q3 2017$1,743,000
+63.5%
90,3000.0%0.29%
+41.3%
Q2 2017$1,066,000
-5.8%
90,300
-12.6%
0.21%
-7.6%
Q1 2017$1,132,000103,3000.22%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,712,176$123,147,0006.01%
TANAKA CAPITAL MANAGEMENT INC 74,139$1,048,0003.38%
S&T BANK/PA 625,078$8,859,0001.92%
Parallel Advisors, LLC 1,277,851$18,062,0001.55%
AJ WEALTH STRATEGIES, LLC 595,828$8,422,0001.11%
Matarin Capital Management, LLC 891,636$12,603,0000.95%
Capital Impact Advisors, LLC 162,544$2,370,0000.90%
AMI ASSET MANAGEMENT CORP 775,685$10,964,0000.57%
Birchview Capital, LP 50,000$707,0000.47%
Zebra Capital Management LLC 25,409$359,0000.39%
View complete list of CORCEPT THERAPEUTICS INC shareholders